Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019

Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019

Abstract Background Nirmatrelvir-ritonavir is currently not recommended in patients with an estimated glomerular filtration rate (eGFR)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2023-11, Vol.77 (10), p.1406-1412
Hauptverfasser: Chan, Gordon Chun Kau, Lui, Grace Chung Yan, Wong, Candy Ngai Sze, Yip, Sindy Sin Ting, Li, Timothy Chun Man, Cheung, Catherine Siu King, Sze, Ryan Kin Ho, Szeto, Cheuk Chun, Chow, Kai Ming
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Antiviral Agents - adverse effects
COVID-19
COVID-19 Drug Treatment
Humans
Kidney Failure, Chronic
Lactams
Leucine
Nitriles
Proline
Prospective Studies
Renal Insufficiency, Chronic - complications
Ritonavir - adverse effects
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Nirmatrelvir-ritonavir is currently not recommended in patients with an estimated glomerular filtration rate (eGFR)
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciad371